News and events2020-03-20T13:22:01+00:00

React4life in the global news

Our Organ On-Chip device at EUROoCs2020

At the European Organ-On-Chip Society meeting we will present: “3D Human Tissues Within The MIVO-Multi In Vitro Organ Fluidic Device for Improving The Outcome Of In Vitro Drug Testing Assays” to demonstrate how the MIVO® platform combined with 3D human tissues can they represent a novel, highly reliable and easy to use in vitro model of interface phenomena for the study of the passage of bioactive drug molecules and their effect on cell behavior. EUROoCS Conference 2020 logo Another important appointment for React4life in an European contest. We are speaking about the annual meeting Euroocs, the European [...]

July 6th, 2020|

React4life among the top 23 EIC-funded SMEs to meet ROCHE

For the third straight year, the European Innovation Council has organized the EIC Corporate Days, gathering innovative European SMEs and large corporates to take full advantage of partnering opportunities. This year, the pharmaceutical giant ROCHE was also invited to meet EIC-funded SMEs and participate in the EIC Corporate Day initiative. From 22 till 25 June 2020, a limited hand-picked number of EIC companies had the opportunity to pitch and present their innovative solutions and to engage in One-to-One Business meetings with Roche representatives. The selected EIC-funded SMEs had also the opportunity to attend the Roche Partnering for Innovation Summit Summit, with [...]

July 3rd, 2020|

Webinar “Is the future goal reduce animal tests on research?

What we really know about drug tests: advantages and disadvantages of 3R methods and animal tests.  The principles of 3R (replacement, reduction and refinement) were developed over 50 years ago to conduct research on more human animals. Biomedical research requires continuous updating on solid experimental models and in this scenario 3R-based approaches can become interesting alternatives in preclinical studies. Thursday 11th June 2020 at 15:00 PM, four researchers from different research sectors present their activity and confront each other trying to answer the following question: will we ever be able to totally replace animal tests? Register for the webinar [...]

June 4th, 2020|

Our Absorption test is the innovative solution to the EU regulation 2017/745 relating to medical devices

Due to the health emergency of Covid19, on Thursday 23 April 2020 the European Council approved and formalized the one-year extension of the 2017/745 Regulation on medical devices, postponing their application until 26 May 2021 (https://data.consilium.europa.eu/doc/document/ST-7180-2020-INIT/en/pdf).  What research areas are involved, and what it foresees this legislation, for a specific type of device, we tell it in this article, proposing our patented solution. Recently the Regulation that affects medical devices has been revised: the Parliament and the European Council have approved the following two regulations amending the existing ones. We are talking about the EU regulation 2017/745, relating to [...]

May 28th, 2020|

Join our free webinar “3D human tissues and fluid-dynamic Multi-In Vitro Organ-MIVO device for in vitro testing”, Tuesday 19th May at 2:30 pm

Are organoids and organ-on-chip the future of scientific research? With the right technology the answer is yes! Our CSO, Silvia Scaglione, introduces in this webinar the potentiality of the React4life’s patented core technologies MIVO, the fluid-dynamic multi-chamber device that allows to recreate in lab human complex systems for improving the in vitro 3D tissue culture and carrying out reliable molecule/drug testing. Subscribe it now: https://us02web.zoom.us/webinar/register/WN_K29h70_1RIyYcNi_t6Nc6w Who it is for: Scientists and innovators of pharma companies, testing companies, CRO and research entities (universities and R&D centers). About the speaker Dr. Silvia Scaglione studied Biomedical Engineering at the University of Genova [...]

May 12th, 2020|

To each his own therapy. Organoids, test in vitro and MIVO devices to test specific treatments suggested by our own cells

The technology allows us to use the so-called organoids, three-dimensional (3D) structures formed by the cells extracted from the patient himself, for in vitro tests aimed at identifying the most effective drug. Everyone is talking about personalized medicine very often, but what exactly does it mean, and how could it be possibly implemented? The model of personalized medicine proposes the personalization of the therapy, and therefore, the use of medical decisions and drugs that are specifically selected for the patient. In fact, each person is unique, and therefore his therapy must also be so. Science has shown that cancer [...]

April 24th, 2020|

Get in Touch

We’d love to hear from you.

Stay updated
Stay updated
Buy Our products
buy our products